Literature DB >> 21194167

Age of Pseudomonas aeruginosa acquisition and subsequent severity of cystic fibrosis lung disease.

Jessica E Pittman1, Elizabeth H Calloway, Michelle Kiser, John Yeatts, Stephanie D Davis, Mitchell L Drumm, Michael S Schechter, Margaret W Leigh, Mary Emond, Annelies Van Rie, Michael R Knowles.   

Abstract

RATIONALE: Pseudomonas aeruginosa (Pa) is associated with poor pulmonary outcomes in cystic fibrosis (CF), but the association between age of Pa infection and severity of subsequent lung disease has not been thoroughly investigated.
OBJECTIVE: Our goal was to determine the association between age of Pa acquisition and subsequent severity of CF lung disease.
METHODS: Case-control study using CF Foundation Registry data of 629 ΔF508 homozygotes with severe and mild lung disease (FEV1 in the lowest and highest quartile of birth cohort, respectively). Multivariate logistic regression was performed to determine the association between age of Pa acquisition and lung disease severity.
RESULTS: Earlier age of Pa infection was strongly associated with increased odds of severe lung disease. For first and persistent Pa, adjusted odds ratios for severe lung disease were 6.5 (95% CI 3.1, 13.7; P < 0.0001) and 11.2 (5.4, 23.1; P < 0.0001), respectively, for subjects with infection before age 5 versus at ≥ 10 years; the association was stronger in females than males.
CONCLUSIONS: Earlier Pa infection, particularly before 5 years of age, is strongly associated with severe CF lung disease later in life. This study is not designed to determine causality; Pa infection may be causing lung injury, or may be a marker of ongoing inflammation and lung damage in young children with CF.
Copyright © 2010 Wiley-Liss, Inc.

Entities:  

Keywords:  epidemiology; infection; lung diseases; obstructive; pediatrics

Mesh:

Year:  2010        PMID: 21194167      PMCID: PMC4239995          DOI: 10.1002/ppul.21397

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  29 in total

1.  Acquisition of Pseudomonas aeruginosa in children with cystic fibrosis.

Authors:  P M Farrell; G Shen; M Splaingard; C E Colby; A Laxova; M R Kosorok; M J Rock; E H Mischler
Journal:  Pediatrics       Date:  1997-11       Impact factor: 7.124

2.  Risk factors for initial acquisition of Pseudomonas aeruginosa in children with cystic fibrosis identified by newborn screening.

Authors:  Judith H Maselli; Marci K Sontag; Jill M Norris; Todd MacKenzie; Jeff S Wagener; Frank J Accurso
Journal:  Pediatr Pulmonol       Date:  2003-04

3.  Predictors of deterioration of lung function in cystic fibrosis.

Authors:  C Schaedel; I de Monestrol; L Hjelte; M Johannesson; R Kornfält; A Lindblad; B Strandvik; L Wahlgren; L Holmberg
Journal:  Pediatr Pulmonol       Date:  2002-06

4.  Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis.

Authors:  J L Burns; R L Gibson; S McNamara; D Yim; J Emerson; M Rosenfeld; P Hiatt; K McCoy; R Castile; A L Smith; B W Ramsey
Journal:  J Infect Dis       Date:  2000-12-27       Impact factor: 5.226

5.  Influence of gender and interleukin-10 deficiency on the inflammatory response during lung infection with Pseudomonas aeruginosa in mice.

Authors:  Claudine Guilbault; Peter Stotland; Claude Lachance; Mifong Tam; Anna Keller; Luann Thompson-Snipes; Elizabeth Cowley; Thomas A Hamilton; David H Eidelman; Mary M Stevenson; Danuta Radzioch
Journal:  Immunology       Date:  2002-11       Impact factor: 7.397

6.  Respiratory infections in cystic fibrosis patients caused by virus, chlamydia and mycoplasma--possible synergism with Pseudomonas aeruginosa.

Authors:  N T Petersen; N Høiby; C H Mordhorst; K Lind; E W Flensborg; B Bruun
Journal:  Acta Paediatr Scand       Date:  1981-09

7.  Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients.

Authors:  Tim W R Lee; Keith G Brownlee; Steven P Conway; Miles Denton; James M Littlewood
Journal:  J Cyst Fibros       Date:  2003-03       Impact factor: 5.482

8.  Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis.

Authors:  Julia Emerson; Margaret Rosenfeld; Sharon McNamara; Bonnie Ramsey; Ronald L Gibson
Journal:  Pediatr Pulmonol       Date:  2002-08

Review 9.  Pseudomonas acquisition in young patients with cystic fibrosis: pathophysiology, diagnosis, and management.

Authors:  Margaret Rosenfeld; Bonnie W Ramsey; Ronald L Gibson
Journal:  Curr Opin Pulm Med       Date:  2003-11       Impact factor: 3.155

10.  Respiratory infections with Pseudomonas aeruginosa in children with cystic fibrosis: early detection by serology and assessment of risk factors.

Authors:  Susan E H West; Lan Zeng; Bee Leng Lee; Michael R Kosorok; Anita Laxova; Michael J Rock; Mark J Splaingard; Philip M Farrell
Journal:  JAMA       Date:  2002-06-12       Impact factor: 157.335

View more
  17 in total

1.  Gene expression in transformed lymphocytes reveals variation in endomembrane and HLA pathways modifying cystic fibrosis pulmonary phenotypes.

Authors:  Wanda K O'Neal; Paul Gallins; Rhonda G Pace; Hong Dang; Whitney E Wolf; Lisa C Jones; XueLiang Guo; Yi-Hui Zhou; Vered Madar; Jinyan Huang; Liming Liang; Miriam F Moffatt; Garry R Cutting; Mitchell L Drumm; Johanna M Rommens; Lisa J Strug; Wei Sun; Jaclyn R Stonebraker; Fred A Wright; Michael R Knowles
Journal:  Am J Hum Genet       Date:  2015-01-29       Impact factor: 11.025

2.  Heritability of respiratory infection with Pseudomonas aeruginosa in cystic fibrosis.

Authors:  Deanna M Green; J Michael Collaco; Kathryn E McDougal; Kathleen M Naughton; Scott M Blackman; Garry R Cutting
Journal:  J Pediatr       Date:  2012-02-23       Impact factor: 4.406

3.  Repeated isolation of an antibiotic-dependent and temperature-sensitive mutant of Pseudomonas aeruginosa from a cystic fibrosis patient.

Authors:  Daniel J Wolter; Alison Scott; Catherine R Armbruster; Dale Whittington; John S Edgar; Xuan Qin; Anne Marie Buccat; Sharon McNamara; Marcella Blackledge; Adam Waalkes; Stephen J Salipante; Robert K Ernst; Lucas R Hoffman
Journal:  J Antimicrob Chemother       Date:  2021-02-11       Impact factor: 5.790

Review 4.  Antibacterial contact-dependent proteins secreted by Gram-negative cystic fibrosis respiratory pathogens.

Authors:  Cristian V Crisan; Joanna B Goldberg
Journal:  Trends Microbiol       Date:  2022-04-26       Impact factor: 18.230

5.  Early Childhood Risk Factors for Decreased FEV1 at Age Six to Seven Years in Young Children with Cystic Fibrosis.

Authors:  Don B Sanders; Julia Emerson; Clement L Ren; Michael S Schechter; Ronald L Gibson; Wayne Morgan; Margaret Rosenfeld
Journal:  Ann Am Thorac Soc       Date:  2015-08

6.  Galectin-9 signaling through TIM-3 is involved in neutrophil-mediated Gram-negative bacterial killing: an effect abrogated within the cystic fibrosis lung.

Authors:  Isabel Vega-Carrascal; David A Bergin; Oliver J McElvaney; Cormac McCarthy; Nessa Banville; Kerstin Pohl; Mitsuomi Hirashima; Vijay K Kuchroo; Emer P Reeves; Noel G McElvaney
Journal:  J Immunol       Date:  2014-01-29       Impact factor: 5.422

7.  Early acquisition and conversion of Pseudomonas aeruginosa in Hispanic youth with cystic fibrosis in the United States.

Authors:  Meghan E McGarry; Chiung-Yu Huang; Dennis W Nielson; Ngoc P Ly
Journal:  J Cyst Fibros       Date:  2020-11-05       Impact factor: 5.482

8.  Inflammasome Genetic Variants, Macrophage Function, and Clinical Outcomes in Cystic Fibrosis.

Authors:  Andrew D Graustein; William R Berrington; Kati J Buckingham; Felicia K Nguyen; Lara L Joudeh; Margaret Rosenfeld; Michael J Bamshad; Ronald L Gibson; Thomas R Hawn; Mary J Emond
Journal:  Am J Respir Cell Mol Biol       Date:  2021-08       Impact factor: 6.914

9.  Phenotypic diversity within a Pseudomonas aeruginosa population infecting an adult with cystic fibrosis.

Authors:  Shawn T Clark; Julio Diaz Caballero; Mary Cheang; Bryan Coburn; Pauline W Wang; Sylva L Donaldson; Yu Zhang; Mingyao Liu; Shaf Keshavjee; Yvonne C W Yau; Valerie J Waters; D Elizabeth Tullis; David S Guttman; David M Hwang
Journal:  Sci Rep       Date:  2015-06-05       Impact factor: 4.379

10.  Association between insurance variability and early lung function in children with cystic fibrosis.

Authors:  Kimberly M Dickinson; Kevin J Psoter; Kristin A Riekert; Joseph M Collaco
Journal:  J Cyst Fibros       Date:  2021-06-24       Impact factor: 5.482

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.